98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12174170 | PMC |
http://dx.doi.org/10.1007/s11748-025-02128-z | DOI Listing |
Naunyn Schmiedebergs Arch Pharmacol
September 2025
Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.
JACC Case Rep
September 2025
Pericardial Disease Program, MedStar Heart and Vascular Institute, Washington, District of Columbia, USA.
Background: Pericardial involvement is common in systemic lupus erythematosus (SLE) and can lead to recurrent episodes. B cell-targeted therapies are commonly used in the treatment of SLE pericarditis. The management of recurrent lupus pericarditis refractory to B cell-targeted therapy remains challenging.
View Article and Find Full Text PDFAnesthesiology
October 2025
Division of Cardiovascular and Thoracic Anesthesia, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.
Eur Heart J
September 2025
Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus MC, Room Rg-435, Dr. Molewaterplein 40, Rotterdam 3000, The Netherlands.
Eur Heart J
September 2025
Institute of Pharmacology and Toxicology, University Medical Centre Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
Background And Aims: Atrial fibrillation (AF) is a prevalent complication after cardiac surgery, worsening patient outcomes. Considering the established role of Ca2+-handling abnormalities in AF pathogenesis, this study aimed to evaluate if integrating cytosolic Ca2+-handling measurements with clinical risk factors enhances the risk prediction of post-operative AF.
Methods: Clinical data from 558 patients undergoing cardiac surgery without pre-existing AF from two centres were analysed.